Women’s Health Study (WENDY)—a protocol of a population-based study assessing gynecological and metabolic health in women in their mid-30s - Takeaways - MDSpire

Women’s Health Study (WENDY)—a protocol of a population-based study assessing gynecological and metabolic health in women in their mid-30s

  • By

  • Terhi T Piltonen

  • Maria Ohtamaa

  • Riikka K Arffman

  • Lotta Vuokila

  • Elisa Hurskainen

  • Minna Männikkö

  • Laura Huilaja

  • Suvi-Päivikki Sinikumpu

  • Tero Rautio

  • Katariina Kilpivaara

  • Jari Jokelainen

  • Eetu Kiviniemi

  • Pekka Pinola

  • Minna Törnävä

  • Elina Komsi

  • Marika H Kangasniemi

  • Maria Rajecki

  • Kaisu Luiro

  • Jenni Kinnunen

  • Susanna M Savukoski

  • August 3, 2024

  • 0 min

Share

  • 1

    The WENDY study investigated gynecological and metabolic health among women aged 33 to 37 in Finland from May 2020 to October 2022.

  • 2

    A total of 1918 women participated, with data collected through clinical measurements, biological samples, and extensive questionnaires.

  • 3

    WENDY is one of the largest datasets globally for studying women's reproductive and metabolic health, linking data from national registers.

  • 4

    The study aims to improve diagnostics, health awareness, and develop novel tools for addressing gynecological health issues.

  • 5

    Participants included women from the Northern Finland Birth Cohort, allowing for comprehensive longitudinal health data analysis.

Original Source(s)

Women’s Health Study (WENDY)—a protocol of a population-based study assessing gynecological and metabolic health in women in their mid-30s

  • by Terhi T Piltonen, Maria Ohtamaa, Riikka K Arffman, Lotta Vuokila, Elisa Hurskainen, Minna Männikkö, Laura Huilaja, Suvi-Päivikki Sinikumpu, Tero Rautio, Katariina Kilpivaara, Jari Jokelainen, Eetu Kiviniemi, Pekka Pinola, Minna Törnävä, Elina Komsi, Marika H Kangasniemi, Maria Rajecki, Kaisu Luiro, Jenni Kinnunen, Susanna M Savukoski

  • August 3, 2024

Related Content

A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.